Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Understanding the Decline in Affirm (AFRM) Stock Today

Affirm stock is trading -11.62% below its average target price of $63.06 after dropping -1.8% during today's afternoon session. Analysts are giving the Large-Cap Diversified Financial company an average rating of buy and target prices ranging from $20.0 to $82.0 per share.

Affirm has an average level of shares sold short, at 5.6% of its total share float. The stock's short ratio (also called days to cover) is 2.18. The company's insiders own 4.82% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 78.3% of Affirm's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Affirm

Date Reported Holder Percentage Shares Value
2024-09-30 Morgan Stanley 11% 30,194,462 $1,682,737,353
2024-09-30 Capital Research Global Investors 9% 23,793,987 $1,326,038,884
2024-09-30 Vanguard Group Inc 8% 21,098,989 $1,175,846,647
2024-09-30 Capital World Investors 7% 18,266,583 $1,017,996,662
2024-09-30 Baillie Gifford and Company 4% 9,935,768 $553,720,346
2024-09-30 Blackrock Inc. 4% 9,931,000 $553,454,625
2024-09-30 Shaw D.E. & Co., Inc. 2% 5,711,163 $318,283,111
2024-09-30 Jericho Capital Asset Management, LP 2% 4,659,147 $259,654,260
2024-09-30 Geode Capital Management, LLC 1% 3,961,119 $220,753,160
2024-09-30 State Street Corporation 1% 3,942,698 $219,726,557
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS